International Conference and Expo on Parenterals & Injectables

August 17-19, 2015 Chicago, USA

ScientificTracks Abstracts

J Pharm Drug Deliv Res
Challenges in parenteral formulation development studies and an evaluation from QbD point of view
Gulay Yelken Demirel
PDF  |   HTML   
J Pharm Drug Deliv Res
Qualification of extractables & leachables from container closure systems in drug products- Introduction to the Product Quality Institute (PQRI) recommendations
Diane Paskiet
PDF  |   HTML   
J Pharm Drug Deliv Res
Case studies of human flora and spore contamination in clean rooms
Jim Polarine
PDF  |   HTML   
J Pharm Drug Deliv Res
The review of flexible production platforms for pharma/biopharmaceutical processing
Maik W Jornitz
PDF  |   HTML   
J Pharm Drug Deliv Res
The value of the “simulated study” as a tool to predict actual leachables in parenteral drug products
Carsten Worsoe
PDF  |   HTML   
J Pharm Drug Deliv Res
Global implementation of system-based microbial control for parenteral manufacture
Edward C Tidswell
PDF  |   HTML   
J Pharm Drug Deliv Res
Purity, endotoxin level, and trace metal comparison of different grades of trehalose
Ben Nelson
PDF  |   HTML   
J Pharm Drug Deliv Res
Formation of inherent protein aggregates in the visible and sub-visible size range by excessive and inhomogeneous lubrication in syringes and cartridges
Oliver K Valet
PDF  |   HTML   
J Pharm Drug Deliv Res
Contract research and development and /or manufacturing of parenteral products: Steps for building a successful and mutually beneficial partnership
Neervalur V Raghavan
PDF  |   HTML   
J Pharm Drug Deliv Res
TBA
Oliver K Valet
PDF  |   HTML   
J Pharm Drug Deliv Res
Extractable and leachable studies of parenteral infusion and transfusion products
Jianfeng Hong, Dujuan Lu, Ming Du and Robert Payton
PDF  |   HTML   
J Pharm Drug Deliv Res
Systematic approach to development of aqueous drug formulation and drug device combination injectable products and challenges
Neervalur V Raghavan
PDF  |   HTML   
J Pharm Drug Deliv Res
Development of co-formulations of monoclonal antibodies and recombinant human hyaluronidase (rHuPH20)
Claudia Mueller
PDF  |   HTML   
J Pharm Drug Deliv Res
Adapting Drug Product Manufacturing Strategy and Processes for Pre-Sterilized, Ready-to- Use (RTU) Vials, Syringes & Cartridges
Josh Russell
PDF  |   HTML   
J Pharm Drug Deliv Res
Compatibility assessment of a model monoclonal antibody formulation in glass and in blow-fill-seal (BFS) plastic vial delivery formats
Dipesh Shah
PDF  |   HTML   
J Pharm Drug Deliv Res
Drug delivery device strategy for patient centric therapies
Li-Chun Tsou
PDF  |   HTML   
J Pharm Drug Deliv Res
Disruption in the US machine tool industry: The role of in house users and pre-disruption component experience in firm response
Raja Roy and Susan Cohen
PDF  |   HTML   
J Pharm Drug Deliv Res
Human Factor Study for Combination Products and Medical Devices
Li-Chun Tsou
PDF  |   HTML   

Track Your Manuscript

Media Partners

GET THE APP